(AMAL) Amalgamated Bank - Ratings and Ratios
Deposits, Loans, Trust Services, Investment Funds, Online Banking
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.71% |
| Yield on Cost 5y | 4.51% |
| Yield CAGR 5y | 9.50% |
| Payout Consistency | 99.3% |
| Payout Ratio | 15.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Value at Risk 5%th | 49.0% |
| Relative Tail Risk | -8.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -16.35 |
| CAGR/Max DD | 0.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.594 |
| Beta | 0.853 |
| Beta Downside | 0.916 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.70% |
| Mean DD | 16.25% |
| Median DD | 15.62% |
Description: AMAL Amalgamated Bank November 30, 2025
Amalgamated Financial Corp. (NASDAQ: AMAL) is the holding company for Amalgamated Bank, offering a full suite of commercial and retail banking services-including interest-bearing and non-interest-bearing deposits, various loan products (residential, commercial, multifamily, and consumer solar), and digital cash-management tools-as well as trust, custody, and investment-management solutions such as index and actively-managed funds across equity, fixed-income, real estate, and alternatives.
Key recent metrics suggest the bank is navigating a challenging regional-bank environment: Q3 2024 net interest margin (NIM) hovered around 2.6%-slightly above the industry median of 2.4%-while loan growth decelerated to 3.1% YoY, reflecting tighter credit standards amid rising Fed rates. Deposits have risen modestly (≈2% YoY), driven in part by higher-yield money-market and CD offerings, and the bank’s loan-to-deposit ratio remains at a conservative 73%, providing a buffer against potential liquidity stress. The broader sector is sensitive to interest-rate cycles, credit-quality trends, and regulatory capital requirements, all of which shape Amalgamated’s earnings outlook.
For a deeper quantitative view, you may want to explore Amalgamated’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (102.3m TTM) > 0 and > 6% of Revenue (6% = 26.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1573 % (prev -1593 %; Δ 19.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 127.6m > Net Income 102.3m (YES >=105%, WARN >=100%) |
| Net Debt (-25.3m) to EBITDA (143.5m) ratio: -0.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.4m) change vs 12m ago -1.62% (target <= -2.0% for YES) |
| Gross Margin 69.09% (prev 70.08%; Δ -0.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.24% (prev 5.10%; Δ 0.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.13 (EBITDA TTM 143.5m / Interest Expense TTM 123.9m) >= 6 (WARN >= 3) |
Altman Z'' -4.94
| (A) -0.81 = (Total Current Assets 727.3m - Total Current Liabilities 7.77b) / Total Assets 8.68b |
| (B) 0.06 = Retained Earnings (Balance) 544.9m / Total Assets 8.68b |
| (C) 0.02 = EBIT TTM 139.9m / Avg Total Assets 8.55b |
| (D) 0.06 = Book Value of Equity 510.0m / Total Liabilities 7.91b |
| Total Rating: -4.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.79
| 1. Piotroski 2.50pt |
| 2. FCF Yield 32.53% |
| 3. FCF Margin 27.85% |
| 4. Debt/Equity 0.12 |
| 5. Debt/Ebitda -0.18 |
| 6. ROIC - WACC (= 0.98)% |
| 7. RoE 13.76% |
| 8. Rev. Trend 91.57% |
| 9. EPS Trend 82.00% |
What is the price of AMAL shares?
Over the past week, the price has changed by +1.77%, over one month by +12.28%, over three months by +17.85% and over the past year by -1.18%.
Is AMAL a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AMAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | -2.5% |
| Analysts Target Price | 32 | -2.5% |
| ValueRay Target Price | 36.6 | 11.5% |
AMAL Fundamental Data Overview December 16, 2025
P/E Trailing = 9.6355
P/S = 3.1381
P/B = 1.2348
Beta = 0.834
Revenue TTM = 447.7m USD
EBIT TTM = 139.9m USD
EBITDA TTM = 143.5m USD
Long Term Debt = 75.5m USD (from longTermDebt, last quarter)
Short Term Debt = 10.8m USD (from shortTermDebt, last fiscal year)
Debt = 90.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -25.3m USD (from netDebt column, last quarter)
Enterprise Value = 383.2m USD (963.2m + Debt 90.3m - CCE 670.2m)
Interest Coverage Ratio = 1.13 (Ebit TTM 139.9m / Interest Expense TTM 123.9m)
FCF Yield = 32.53% (FCF TTM 124.7m / Enterprise Value 383.2m)
FCF Margin = 27.85% (FCF TTM 124.7m / Revenue TTM 447.7m)
Net Margin = 22.85% (Net Income TTM 102.3m / Revenue TTM 447.7m)
Gross Margin = 69.09% ((Revenue TTM 447.7m - Cost of Revenue TTM 138.4m) / Revenue TTM)
Gross Margin QoQ = 67.47% (prev 67.81%)
Tobins Q-Ratio = 0.04 (Enterprise Value 383.2m / Total Assets 8.68b)
Interest Expense / Debt = 36.71% (Interest Expense 33.1m / Debt 90.3m)
Taxrate = 26.98% (9.90m / 36.7m)
NOPAT = 102.2m (EBIT 139.9m * (1 - 26.98%))
Current Ratio = 0.09 (Total Current Assets 727.3m / Total Current Liabilities 7.77b)
Debt / Equity = 0.12 (Debt 90.3m / totalStockholderEquity, last quarter 775.6m)
Debt / EBITDA = -0.18 (Net Debt -25.3m / EBITDA 143.5m)
Debt / FCF = -0.20 (Net Debt -25.3m / FCF TTM 124.7m)
Total Stockholder Equity = 743.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.18% (Net Income 102.3m / Total Assets 8.68b)
RoE = 13.76% (Net Income TTM 102.3m / Total Stockholder Equity 743.3m)
RoCE = 17.09% (EBIT 139.9m / Capital Employed (Equity 743.3m + L.T.Debt 75.5m))
RoIC = 11.65% (NOPAT 102.2m / Invested Capital 877.1m)
WACC = 10.67% (E(963.2m)/V(1.05b) * Re(9.16%) + D(90.3m)/V(1.05b) * Rd(36.71%) * (1-Tc(0.27)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.34%
[DCF Debug] Terminal Value 75.51% ; FCFE base≈118.4m ; Y1≈127.6m ; Y5≈157.3m
Fair Price DCF = 75.07 (DCF Value 2.25b / Shares Outstanding 29.9m; 5y FCF grow 8.76% → 3.0% )
EPS Correlation: 82.00 | EPS CAGR: 17.31% | SUE: 0.86 | # QB: 1
Revenue Correlation: 91.57 | Revenue CAGR: 22.39% | SUE: 1.10 | # QB: 16
EPS next Quarter (2026-03-31): EPS=0.92 | Chg30d=-0.040 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=-0.145 | Revisions Net=+0 | Growth EPS=+11.3% | Growth Revenue=+8.0%
Additional Sources for AMAL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle